Today, the University of Florida Health Cancer Center celebrates Juneteenth and reflects on the needs of our community and cancer patients. It is notable that our area continues to have some of the highest rates of breast, cervical, lung and prostate cancer.
The University of Florida Health Cancer Center is pleased to announce that Luisel J. Ricks-Santi, Ph.D., has been appointed associate director for diversity, equity and inclusion, effective April 1, 2022. Dr. Luisel Ricks-Santi In the role of associate director for diversity, equity and inclusion, Dr. Ricks-Santi will join the…
Physicians and researchers from the University of Florida are participating in the American Society of Clinical Oncology (ASCO) Annual Meeting held on June 3-7, 2022 in Chicago, IL. The ASCO Annual Meeting is one of the largest gatherings of medical professionals in the world. It brings together more than 25,000…
Gov. Ron DeSantis announced that he will approve $100 million for cancer research and treatment in the state’s 2022-2023 spending plan — an increase of about $37 million over the current budget. Three Florida cancer centers — the UF Health Cancer Center, Sylvester Comprehensive Cancer Center and H. Lee Moffitt Cancer Center and Research Institute — will receive the funding for research and medical care.
Dacia’s team of UF Health physicians – primary care, oncologist, surgeon, and radiation oncologist – coordinated her care and developed an optimal treatment plan to include a lumpectomy followed by 32 daily treatments of proton therapy.
The UF Health Cancer Center was well represented at the ASCO Gastrointestinal Cancers Symposium that was held virtually and in-person in San Francisco, Calif., on Jan. 20-22, 2022.
Through various community events, the UF Health Cancer Center continues to be committed to reducing cancer-related health disparities and amplifying community strengths.
Brain cancer researchers, clinicians, survivors and supporters from across the U.S. and beyond united in person for the first time in more than two years for the 4th Annual ReMission Summit for Brain Tumors.
The functional relationship between immunity, intestinal microbiota and non-small cell lung cancer (NSCLC) response to immune checkpoint inhibitors (ICI) PD1 in an American cohort remains unexplored. In a new Genome Medicine study titled, “Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohort,” Christian Jobin, Ph.D., co-leader of the Cancer Center’s Cancer Therapeutics and Host Response research program, PhD student Rachel Newsome and Raad Gharaibeh Ph.D., microbial genomic expert, ( Jobin Research Lab team), explore this unknown.
First ladies of churches in Gainesville and surrounding areas gathered to discuss the well-being of the health of women in their congregations. The discussion was hosted by the University of Florida Health Cancer Center and Community Outreach and Engagement (COE) Steering Committee. Billed as the Leading Ladies Brunch, the event was held Saturday at Open Door Ministries located at 601 NE 19th St. to inspire first ladies of churches in the area to encourage female parishioners to get screened more for cervical cancer.
